NOMAD POWER SOLUTIONS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $31.99 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-08-14
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2026-06-30 was $31.99K, a 88.06% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2026-03-31 was $82.18K, a 17.61% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-06-30 was $268.00K.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-03-31 was $99.74K.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $1.39M, a 232.06% increase from fiscal 2024.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $418.00K.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2020 was $100.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $31.99K 10-Q · filed 2026-08-14 | $114.16K 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $82.18K 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $1.39M 10-K · filed 2026-03-31 | |||
| 2025-06-30 | $268.00K 10-Q · filed 2026-08-14 | $367.74K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $99.74K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $418.00K 10-K · filed 2026-03-31 | |||
| 2020-12-31 | $100.00K 10-K · filed 2021-03-26 | |||
| 2019-05-22 | $189.06K 10-K · filed 2021-03-26 | |||
| 2016-03-31 | -$30.37K 10-Q · filed 2016-05-06 | |||
| 2014-07-15 | $43.50K 10-K · filed 2015-03-27 | |||
| 2011-06-30 | $196.00K 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |